Like CSL and SHL, RMD suffers more than most in rising interest times. The Medical area can be tough at the best of times, low Yields vs Rising Term Deposit rates can be a real drag on share prices. CSL, SHL and RMD are all great companies but rise and fall with the broader tide of interest rates. More so if they carry large borrowings.
Ann: ResMed Announces Results for the Fourth Quarter of FY2023, page-287
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$37.39 |
Change
0.390(1.05%) |
Mkt cap ! $22.84B | |||
| Open | High | Low | Value | Volume |
| $37.30 | $37.39 | $37.07 | $9.729M | 260.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 44 | $37.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $37.39 | 2573 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |